BAY.MI - Bayer Aktiengesellschaft

Milan - Milan Delayed Price. Currency in EUR
117.50
-0.80 (-0.68%)
At close: 3:59PM CEST
Stock chart is not supported by your current browser
Previous Close118.30
Open118.60
Bid0.00 x 0
Ask0.00 x 0
Day's Range117.50 - 118.60
52 Week Range86.10 - 123.80
Volume882
Avg. Volume971
Market Cap97.19B
BetaN/A
PE Ratio (TTM)20.33
EPS (TTM)5.78
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est125.00
  • American City Business Journals4 days ago

    As Bayer preps to vacate RTP, BASF readies for growth

    As Bayer prepares to totally vacate its Research Triangle Park facilities, BASF readies to move in. The deal is connected with Bayer’s pending buy of Monsanto, which relocates Bayer’s North American Commercial and Seeds and Traits divisions to St. Louis from RTP. BASF's buy is “driven by growth potential,” and not by “synergies,” Paul Rea, senior vice president of BASF Crop Protection, North America, told reporters.

  • The Zacks Analyst Blog Highlights: Bayer Aktiengesellschaft, Monsanto, Adaptimmune Therapeutics and Celgene
    Zacks4 days ago

    The Zacks Analyst Blog Highlights: Bayer Aktiengesellschaft, Monsanto, Adaptimmune Therapeutics and Celgene

    The Zacks Analyst Blog Highlights: Bayer Aktiengesellschaft, Monsanto, Adaptimmune Therapeutics and Celgene

  • Bayer to Sell Select Business Lines to Close Monsanto Buyout
    Zacks5 days ago

    Bayer to Sell Select Business Lines to Close Monsanto Buyout

    Bayer Aktiengesellschaft (BAYRY) inked a deal to sell selected Crop Science businesses to BASF for EUR 5.9 billion to as a part of its strategy to complete the planned acquisition of Monsanto Co.

  • The Wall Street Journal8 days ago

    [$$] Bayer to Sell Assets to BASF for $7 Billion Amid Scrutiny of Monsanto Megadeal

    Bayer said it has agreed to sell parts of its crop-science business to rival BASF, a bid to assuage regulators as the German chemical conglomerate seeks approval for its $57 billion acquisition of U.S. ...

  • American City Business Journals8 days ago

    Bayer crop science deal won't include KC facility

    Bayer AG's plans to sell a portion of its crop science division will not include its Kansas City manufacturing facility, a company spokesman confirmed Friday. On Thursday evening, Bayer announced that it planned to offload its field crop seeds business and a portion of its herbicide business to German chemical company BASF SE for $7 billion. The Kansas City operation produces herbicides, fungicides and pesticides.

  • American City Business Journals8 days ago

    Monsanto deal prompts Bayer to sell pieces of unit with big KC presence

    Bayer AG has a deal to sell off parts of a division to rival BASF SE to help partially refinance its $57 billion purchase of St. Louis-based Monsanto Co. and to calm regulators concerned about antitrust issues in the U.S. and the European Union. The Wall Street Journal reports that Germany-based Bayer plans to sell its crop seeds business, a portion of its Crop Science division, for $6.98 billion. Together, Bayer’s and Monsanto’s control of the market could put pressure on farmers that already face low crop prices, EU regulators have said.

  • American City Business Journals8 days ago

    Bayer to sell assets to BASF, 300 in RTP impacted

    As Bayer works to finalize its $66 billion buy of Monsanto, the German firm is finally talking about what will happen to some of its businesses in Research Triangle Park. Bayer has reached an agreement to sell parts of its Crop Science businesses to BASF, which also has a major RTP operation, for about $7 billion.

  • BASF to harvest seeds, herbicide businesses from Bayer for $7 billion
    Reuters8 days ago

    BASF to harvest seeds, herbicide businesses from Bayer for $7 billion

    BASF (BASFn.DE) has agreed to buy seed and herbicide businesses from Bayer (BAYGn.DE) for 5.9 billion euros (5.26 billion pounds)in cash, as Bayer tries to convince competition authorities to approve its planned acquisition of Monsanto (MON.N). BASF, the world's third-largest maker of crop chemicals, has so far avoided seed assets and instead pursued research into plant characteristics such as drought tolerance, which it sells or licenses out to seed developers.

  • Reuters8 days ago

    BASF to harvest seeds, herbicide businesses from Bayer for $7 bln

    BASF has agreed to buy seed and herbicide businesses from Bayer for 5.9 billion euros ($7 billion) in cash, as Bayer tries to convince competition authorities to approve its planned acquisition of Monsanto. BASF, the world's third-largest maker of crop chemicals, has so far avoided seed assets and instead pursued research into plant characteristics such as drought tolerance, which it sells or licenses out to seed developers.

  • BASF Pays for Sitting Out the Chemicals Dance Party
    Bloomberg8 days ago

    BASF Pays for Sitting Out the Chemicals Dance Party

    Bayer's buyer hasn't exactly overpaid, but this is no bargain.

  • Reuters8 days ago

    Bayer's gains help European shares hit four-month high

    European shares hit their highest in nearly four months on Friday, helped by gains in Bayer (BAYGn.DE) after an asset sale deal paving the way for the German drugmaker's $66 billion acquisition of Monsanto (MON.N). The pan-European STOXX 600 (.STOXX) rose 0.3 percent, also underpinned by strength among materials stocks. Germany's DAX (.GDAXI) index was flat, just below the all-time high hit in the previous session, while Britain's FTSE (.FTSE) eased back 0.3 percent after a record close on Thursday.

  • MarketWatch8 days ago

    Germany’s stock market logs another record as Bayer rises on deal news

    European stocks mostly rise on Friday, as Bayer AG shares rally on news the German conglomerate has reached a multibillion-euro deal to sell parts of its business, which helped the DAX register another ...

  • Bayer sells units to be able to complete Monsanto takeover
    Associated Press8 days ago

    Bayer sells units to be able to complete Monsanto takeover

    BERLIN (AP) — German pharmaceutical giant Bayer AG has reached a 5.9 billion euro ($7 billion) deal to sell parts of its Crop Science unit to German chemical company BASF to alleviate regulatory concerns over its planned takeover of U.S. seed and weed-killer company Monsanto Co.

  • TheStreet.com8 days ago

    BASF Agrees to Purchase Bayer's Herbicide Division for €6 Billion

    Sale should help Bayer's $66 billion takeover of Monsanto

  • BASF Enters Seeds Market as Bayer Sells $7 Billion in Assets
    Bloomberg9 days ago

    BASF Enters Seeds Market as Bayer Sells $7 Billion in Assets

    BASF SE agreed to buy part of Bayer AG’s agricultural products business for 5.9 billion euros ($7 billion), seizing the opportunity to enter the genetically-modified seeds market as Bayer sells assets ...

  • BASF Enters Seeds Market as Bayer Sells $7 Billion in Assets
    Bloomberg9 days ago

    BASF Enters Seeds Market as Bayer Sells $7 Billion in Assets

    BASF SE agreed to buy part of Bayer AG’s agricultural products business for 5.9 billion euros ($7 billion), seizing the opportunity to enter the genetically-modified seeds market as Bayer sells assets ...

  • Reuters15 days ago

    Bayer sticks by Xarelto sales estimate despite study setback

    FRANKFURT/BERLIN, Oct 6 (Reuters) - Bayer stood by its peak sales estimate for clot prevention drug Xarelto after the pill disappointed in a late-stage trial to test prevention of repeat strokes. The Phase III study had been halted early after the drug showed no efficacy improvements over low-dose aspirin, Bayer said in a statement late on Thursday.

  • Reuters16 days ago

    Bayer says Phase III Xarelto study halted early

    Bayer and partner Johnson & Johnson suffered a setback for blockbuster clot prevention drug Xarelto, with the German company saying a Phase III study had been halted early after the drug showed no efficacy improvements over low-dose aspirin. The final stage study was evaluating the efficacy and safety of Xarelto, also known as rivaroxaban, for the secondary prevention of stroke and systemic embolism in patients with a recent embolic stroke of undetermined source. "While bleeding rates were low overall, an increase in bleeding was observed in the rivaroxaban arm compared to the low dose aspirin arm," Bayer, which invented aspirin, said in a statement late on Thursday.

  • 4 Large-Cap Drug Stocks to Buy on Solid Momentum Ahead of Q3
    Zacks16 days ago

    4 Large-Cap Drug Stocks to Buy on Solid Momentum Ahead of Q3

    The Large Cap Pharmaceuticals industry has gained 20.7% year to date, outpacing 14.7% gain for the S&P 500.

  • The Wall Street Journal17 days ago

    [$$] Monsanto Boosted by Continued Adoption of New Products

    Continued adoption of new soybean, cotton and corn products drove Monsanto’s quarterly revenue, even amid what it called a challenging agricultural environment.

  • Reuters17 days ago

    Brazil agency says Bayer-Monsanto tie-up can hurt competition, urges conditions

    A unit of Brazil's competition regulator Cade has said Bayer AG's (BAYGn.DE) proposed takeover of Monsanto Co. (MON.N) could be detrimental to competition and urged conditions for Brazilian approval of the corporate tie-up, a document released on the agency's website shows. It recommended what it termed as "structural solutions" as a condition for final approval the deal, which will be in the hands of Cade's seven-member tribunal. The Cade unit said solutions included creating or strengthening another player to compete in the markets for soy and cotton seeds and in the sphere of biotech development.

  • American City Business Journals17 days ago

    Monsanto CEO talks Bayer deal timeline, mum on RTP specifics

    Monsanto (MON) CEO Hugh Grant told investors that Wednesday’s earnings call could be its final full-year conference call under the Monsanto brand. “We anticipate closing on the merger with Bayer at the beginning of the New Year,” he told analysts. “Bayer continues to lead the regulatory filing process, and progress is moving along, as expected, around the world,” he said Wednesday.

  • Reuters17 days ago

    Brazil agency says Bayer-Monsanto tie-up can hurt competition, urges conditions

    A unit of Brazil's competition regulator Cade has said Bayer AG's proposed takeover of Monsanto Co. could be detrimental to competition and urged conditions for Brazilian approval of the corporate tie-up, a document released on the agency's website shows. It recommended what it termed as "structural solutions" as a condition for final approval the deal, which will be in the hands of Cade's seven-member tribunal. In an emailed statement to Reuters, Bayer said the unit's opinion is non-binding and does not mean the transaction will be blocked.

  • Reuters17 days ago

    Monsanto fourth-quarter profit up as corn, soy seed sales jump

    U.S. seeds and agrochemicals company Monsanto Co, which is being acquired by Bayer AG, reported a quarterly profit on Wednesday, compared with a year-ago loss, as seed licensing deals in the typically low-revenue fourth quarter lifted sales. Monsanto shares were up slightly at $119.88 after earlier touching a more-than-two-year high. Sales of corn seeds and traits, Monsanto's biggest segment by revenue, rose nearly 16 percent while soybean seeds and traits sales climbed 22 percent in the quarter ended Aug. 31.

  • Reuters17 days ago

    Monsanto 4th qtr profit up as corn, soy seed sales jump

    U.S. seeds and agrochemicals company Monsanto Co, which is being acquired by Bayer AG , reported a quarterly profit on Wednesday, compared with a year-ago loss, as seed licensing deals in the typically low-revenue fourth quarter lifted sales. Monsanto shares were up slightly at $119.88 after earlier touching a more-than-two-year high. Sales of corn seeds and traits, Monsanto's biggest segment by revenue, rose nearly 16 percent while soybean seeds and traits sales climbed 22 percent in the quarter ended Aug. 31.